Some patients that have received surgical mesh—particularly surgical mesh that has been implanted through the vagina—have had the mesh reduce in size or wear through their vaginal mucosa, according to media announcements. The bodies of other patients have merely rejected surgical mesh (occasionally referred to as “bladder sling”) implants. Because of this, many patients who have received surgical mesh and bladder slings are experiencing dangerous side effects.
The surgical mesh products presently sold or once sold by these companies bear many different names, including:
The FDA first announced a public health notification warning physicians about the dangers linked to surgical mesh in 2008. Issued in response to surgical mesh creators’ receipt of “over 1,000” adverse-event reports linked to attempts to fix POP and Stress Urinary Incontinence (SUI) by placing surgical mesh transvaginally (that is, through a patient’s vagina instead of through her abdomen), the notification stated that such problems were severe, yet unusual.
Between the 2008 release of that Health Safety Communication and 2010, severe complaints about issues linked to the use of surgical mesh to treat POP increased five times the amount, according to the FDA. Additionally, the agency’s orderly review of the applicable scientific literature published from 1996 to 2011 stated that transvaginal POP repair with mesh does not improve symptomatic results or quality of life over normal non-mesh repair.
Did you know?